Volume 30, Issue 140 (May & June 2022)                   J Adv Med Biomed Res 2022, 30(140): 223-231 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Heidari M M, Behzadnia M J, Bahari Z, Azimzadeh Ardabili M H. Assessment of Clinical and Laboratory Data among the Readmitted COVID-19 and Non COVID-19 Patients in Iran. J Adv Med Biomed Res 2022; 30 (140) :223-231
URL: http://journal.zums.ac.ir/article-1-6350-en.html
Assessment of Clinical and Laboratory Data among the Readmitted COVID-19 and Non COVID-19 Patients in Iran
Mohammad Mahdi Heidari1 , Mohammad Javad Behzadnia * 2, Zahra Bahari3 , Mohammad Hossein Azimzadeh Ardabili1
1- Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran
2- Trauma Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran , behzadnia@bmsu.ac.ir
3- Dept. of Physiology and Medical Physics, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran
Abstract:   (91082 Views)

Background and Objective: Hospital readmissions are common and expensive. Identifying the patients who are at high risk of readmission can decrease readmission. Hence, in the present study, the clinical characteristics, biomarker results, and Computed Tomography (CT) criteria of all the readmitted patients were assessed.
Materials and Methods: Data of 98 readmitted patients to the Baqiyatallah Hospital in Tehran reviewed from December 22, 2019 through June 20, 2020. We classified the readmitted patients into three groups: patients (1) without COVID-19 symptoms, (2) with suspected COVID-19, and (3) with confirmed COVID-19 infection.
Results: Our data revealed that the frequency of gender was significantly different between groups (with higher frequency for men). The duration between two admissions were significantly low in the confirmed COVID-19 group. Ischemic heart disease, hypertension, and diabetes mellitus were more common in confirmed COVID-19 group. High levels of CRP, and ESR detected in the confirmed COVID-19 group. During the first admission, the count of WBC was significantly lower in the confirmed COVID-19 group, the RBC count and hemoglobin level was significantly higher in both the first and second admission in the confirmed COVID-19 group. Most of the patient’s had bilateral lung lesions and ground glass opacities (GGO) in their CT Scans in the second admission.
Conclusion: Our data suggested that the older men and ischemic heart disease, hypertension and diabetes mellitus had a high risk of hospital readmission in COVID-19. The confirmed COVID-19 group showed a shorten time to be readmitted.

Keywords: Patient readmission, COVID-19, Risk factors, Comorbidity
Full-Text [PDF 305 kb]   (42013 Downloads) |   |   Full-Text (HTML)  (1341 Views)  

✅ Our data suggested that the older men and ischemic heart disease, hypertension and diabetes mellitus had a high risk of hospital readmission in COVID-19. The confirmed COVID-19 group showed a shorten time to be readmitted.


Type of Study: Original Article | Subject: Clinical medicine
Received: 2021/01/2 | Accepted: 2021/06/10 | Published: 2022/04/1
References
1. Hamid S, Mir MY, Rohela GK. Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics). New Microbes New Infect. 2020; 35: 100679. [DOI:10.1016/j.nmni.2020.100679] [PMID] [PMCID]
2. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020; 215: 108427. [DOI:10.1016/j.clim.2020.108427] [PMID] [PMCID]
3. Ouassou H, Kharchoufa L, Bouhrim M, et al. The Pathogenesis of coronavirus disease 2019 (COVID-19): evaluation and prevention. J Immunol Res. 2020; 2020: 1357983. [DOI:10.1155/2020/1357983] [PMID] [PMCID]
4. Atalla E, Kalligeros M, Giampaolo G, Mylona EK, Shehadeh F, Mylonakis E. Readmissions among patients with COVID-19. Int J Clin Pract. 2020; 13700. [DOI:10.1111/ijcp.13700] [PMID]
5. Felix HC, Seaberg B, Bursac Z, Thostenson J, Stewart MK. Why do patients keep coming back? Results of a readmitted patient survey. Soc Work Health Care. 2015; 54: 1-15. [DOI:10.1080/00981389.2014.966881] [PMID] [PMCID]
6. Jeon WH, Seon JY, Park SY, Oh IH. Analysis of risk factors on readmission cases of COVID-19 in the Republic of Korea: using nationwide health claims data. Int J Environ Res Public Health. 2020; 17(16): 5844. [DOI:10.3390/ijerph17165844] [PMID] [PMCID]
7. Ye S, Hiura G, Fleck E,et al. Hospital readmissions after implementation of a discharge care program for patients with COVID-19 illness. J Gen Intern Med. 2021; 1:1-8. [DOI:10.1007/s11606-020-06340-w] [PMID] [PMCID]
8. Parra Ramirez LM, Cantero M, Morras I, et al. Hospital readmissions of discharged patients with COVID-19. medRxiv. 2020 (In Press). [DOI:10.2147/IJGM.S275775] [PMID] [PMCID]
9. Jeon WH, Seon JY, Park SY, Oh IH. Analysis of risk factors on readmission cases of COVID-19 in the republic of korea: using nationwide health claims data. Int J Environ Res Public Health. 2020; 17(16): 8-12. [DOI:10.3390/ijerph17165844] [PMID] [PMCID]
10. Li XJ, Zhang ZW, Zong ZY. A case of a readmitted patient who recovered from COVID-19 in Chengdu, China. Crit Care. 2020; 24: 152. [DOI:10.1186/s13054-020-02877-8] [PMID] [PMCID]
11. Ghahramani S, Tabrizi R, Lankarani KB, et al. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res. 2020; 25(1):1-0. [DOI:10.1186/s40001-020-00432-3] [PMID] [PMCID]
12. Robinson R, Hudali T. The HOSPITAL score and LACE index as predictors of 30 day readmission in a retrospective study at a university-affiliated community hospital. Peer J. 2017; 5: 3137. [DOI:10.7717/peerj.3137] [PMID] [PMCID]
13. Lam CN, Arora S, Menchine M. Increased 30-day emergency department revisits among homeless patients with mental health conditions. West J Emerg Med. 2016; 17: 607-12. [DOI:10.5811/westjem.2016.6.30690] [PMID] [PMCID]
14. Nordeck CD, Welsh C, Schwartz RP, et al. Rehospitalization and substance use disorder (SUD) treatment entry among patients seen by a hospital SUD consultation-liaison service. Drug Alcohol Depend. 2018; 186: 23-8. [DOI:10.1016/j.drugalcdep.2017.12.043] [PMID] [PMCID]
15. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020; 323(20): 2052-59. [DOI:10.1001/jama.2020.6775] [PMID] [PMCID]
16. Rokadiya S, Gil E, Stubbs C, Bell D, Herbert R. COVID-19: Outcomes of patients with confirmed COVID-19 re-admitted to hospital. J Infect. 2020; 81(3): 18-19. [DOI:10.1016/j.jinf.2020.07.007] [PMID] [PMCID]
17. Possoa M, Comasa M, Romána M, et al. Comorbidities and mortality in patients with COVID-19 aged 60 years and older in a university hospital in Spain. Arch Bronconeumol. 2020 (In Press). [DOI:10.1016/j.arbres.2020.06.012]
18. Smith AL, Murphey LJ, Zaka O, Labrin J, Sopko KL, Sponsler KC. Comorbidities contribute to potentially avoidable hospital readmissions. The Hospitalist. 2014; 10.
19. Zhang L, Kong X, Li X, et al. CT imaging features of 34 patients infected with COVID-19. Clin Imaging. 2020; 68: 226-31. [DOI:10.1016/j.clinimag.2020.05.016] [PMID] [PMCID]
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb